In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target
Xiaoqing Wang(Roche (China)), X. Shirley Liu(Harbin Medical University), Collin Tokheim(Johns Hopkins University), Clifford A. Meyer(Dana-Farber Cancer Institute), Shengqing Gu(Dana-Farber Cancer Institute), Peng Jiang(King Center), Klothilda Lim(Dana-Farber Cancer Institute), Tengfei Xiao(Lanzhou University), Myles Brown(Harvard University), Nicole Traugh(Tongji University), Jingxin Fu(Tongji University), Henry W. Long(Dana-Farber Cancer Institute), Zexian Zeng(Peking University), Qin Tang(University of Electronic Science and Technology of China), Wei Li(Children's National), Yi Zhang(Case Western Reserve University), Ziyi Li(Ministry of Agriculture and Rural Affairs), Binbin Wang(National Cancer Institute), Yihao Li(Second Affiliated Hospital of Guangzhou Medical University), Paloma Cejas(Dana-Farber Cancer Institute), Boning Zhang(Harvard University), Jun Chu(Anhui University of Traditional Chinese Medicine)
Cited by 200
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
|Genome biology|2016|2.8k
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928